<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Q422 Spine Enabling Tech Market Recap

By Shelly Caruso on 5/26/23 10:27 AM

Merger mayhem of Q422 continues and the Spine enabling tech space heats up with new navigation products and some robotics players seeing record-breaking sales and unit placements.

The Q422 WW Spine Enabling Tech Market was up +13.6% YoY, according to SmartTRAK Financial Dashboard. Medtronic (MDT) remained the market leader, followed by Globus Medical (GMED) and other enabling tech competitors like Brainlab and Stryker (SYK). For detailed Q422 revenues and shares by company in the US, EU and ROW, see SmartTRAK Spine Enabling Tech Financial Dashboard*.

Among the many topics explored in detail in this comprehensive Spine Enabling Tech article* are:
  • Complete Q422 Spine Enabling Tech Performance Recap
  • Mighty Mergers in Q422 and Q123
    • SeaSpine and Orthofix Take the Plunge
    • Globus and NuVasive Join Forces in Q123
  • Other Q422 Collaborations
    • ZimVie and Brainlab
    • Spineart and eCential Robotics
    • Captiva Spine and REMEX Medical
  • Q422 Augmented Reality and Navigation Regulatory Highlights

Read the entire Q422 Spine Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK

Topics: Spine CAS Spine
Continue Reading
2 min read

Surviving Economic Storms: Boost YOUR Success with Better Market Intelligence Solutions

By Linda Bernier on 5/21/23 10:00 PM

Boost YOUR Success with Better Market Intelligence Solutions

In these uncertain times, the Medtech Industry is facing economic challenges, which have resulted in countless layoffs, early retirements and stressful budget cuts. As a result, many departments are left without proper staffing, creating major gaps in subject matter expertise and strategic insights. But times of pressure demand push-back from those determined to come out stronger on the other side, which is why now, more than ever, is the time to double down on your investments in market intelligence solutions and better technology.

Technology is a critical investment that can help companies reduce costs and increase efficiency. According to a recent survey by Gartner, an astounding 40% of CFOs say they plan to increase their IT budgets, even in times of economic uncertainty. Automation is also seen as a deflationary force that can help companies boost productivity and reduce costs while maintaining strong barriers to entry, what Morgan Stanley analysts call “deflation enablers.”

SmartTRAK’s Insights-as-a-Service solution has the potential to drive significant savings while also providing a competitive edge for your growth strategies. Just look at some of the potential results investments in SmartTRAK can provide companies:

  • 20 to 25% increase the productivity of knowledge workers
  • 25 - 35% reduction in time searching and gathering information with a searchable record of knowledge
  • 3.5 – 6.5 hours of increased value-added time per week

But the proof is in the pudding. With the kinds of challenges that Medtech companies are facing today, SmartTRAK offers necessary solutions to help ease the burden of inflation. The SmartTRAK insights platformcombined with our subject matter experts can work as an extension of your market intelligence team, keeping you in-the-know and more productive than ever as you weather the economic storm.

If your organization is grappling with the kinds of budget challenges we mentioned while striving for double-digit growth, allow SmartTRAK to help. With a simple discovery call, our team can demonstrate the value and positive impacts of your company’s market intelligence spend. Using our SmartTRAK ROI Modeling tool, we can uncover invisible productivity and consolidation opportunities that can result in cost savings, greater efficiency and a positive ROI. All you have to do is click the button below to reach out to schedule. Schedule My ROI

Continue Reading
2 min read

Beyond Robotics: Enabling Tech Innovations at AAOS 2023

By Elise Wolf on 5/19/23 9:30 AM

More than just robots. Targeting enabling technologies to the ASC setting, development of novel assistive technologies, next-generation software updates, new applications and data insights abound at AAOS 2023.

In the US Markets for Spine and Orthopedic Enabling Technologies, it’s clear that companies are rapidly innovating and designing next-generation technologies that continue to advance the market well beyond the robotic surgical arms and platforms developed in the last decade. At this year’s American Academy of Orthopaedic Surgeons’ (AAOS) Annual Meeting, enabling technology was a big focus both on the podium and the exhibit floor. The Canaccord Genuity (CG) Musculoskeletal Conference also included a number of presentations from companies with innovative enabling technologies, including Enovis, OnPoint Surgical, THINK Surgical, OrthAlign, Augmedics, Canary Medical and newcomer Caira. Additionally, several companies on the AAOS exhibit floor were showcasing new developments across surgical planning, navigation, augmented reality, robotics and smart implants. In this Perspective article, SmartTRAK focuses in on several of the aforementioned companies, exciting technologies and important topics, including:

  • These Are Not Your Father’s Robots: They're Here to Stay
  • ASC Shift Driving Smaller, More Cost-Effective Solutions
  • Dream Becoming Reality: Augmented Reality Competition Heats Up
  • More Than Just Data: Smart Implants Show Promise in Improving Post-op Recovery
  • Enabling Technology Space Continues to Grow
  • Physician Adoption

With a lot of new developments expected later this year and over the next 24-48 months, the enabling technology space continues to grow and physician adoption is ...

To download and read the complete and unedited "Beyond Robotics: Enabling Tech Innovations at AAOS 2023" article by Elise Wolf, GM & VP, SmartTRAK Orthopedics, Digital & Quality, just click the button below. Download the Beyond Robotics Article

Continue Reading
2 min read

Orthobiologics News: The Buzz from AAOS 2023

By Kim French on 5/16/23 9:30 AM

Company efforts to grow share, reduce costs and increase revenue

This year’s American Academy of Orthopaedic Surgeon’s (AAOS) Annual Meeting was well attended, lively and appeared to be “getting back to normal.” The exhibit hall flowed with curious surgeons, industry symposiums and innovation talks were standing room only; the annual meeting was pulsating with robust information and industry news. Compared to previous years, the Orthobiologics buzz at AAOS 2023 was immense, and this article highlights some of the latest news.
 
Among the topics discussed in the complete Perspective article, which is available for download here, are:
  • Top of Mind: M&A and Workforce Reductions
  • Macroeconomic Headwinds
  • Momentum for Penetrating Larger Addressable Markets
  • Companies that are Shifting Strategies
    • Anika Therapeutics - Anika has been transforming itself from an osteoarthritis (OA) pain management leader with a huge addressable market to a ...
    • Vericel - US Cartilage Replacement Market leader Vericel continues to shape the market landscape and shift how surgeons are treating ...
    • CONMED - In 2021, CONMED accelerated investments to grow its domestic Orthopedic business, including expanding its ...
  • Latest Updates on Pricing and Reimbursement

In summary, this year’s AAOS meeting was energetic, and most of the news and information was positive. SmartTRAK is eager to see the outcomes of the recent acquisitions and activities associated with capturing more market share and ...

To read the complete "The Orthobiologics Buzz at AAOS 2023" article by Kimberly French, GM, Orthobiologics and Regenerative Medicine, just click the button below. Download the Orthobio Buzz AAOS 2023 Article

Continue Reading
2 min read

Smooth Water/Turbulent Whitewater: Q422/FY22 US Joint Fluid Replacement Market Recap

By Freddy Buntoum on 5/11/23 12:53 PM

Some HA players navigate through smooth river flows, while others hit turbulent whitewater.

For Q422, CMS reimbursement changes continued to impact overall revenue for the US Joint Fluid Replacement market which represents a decline of -3.3% vs Q421 according to SmartTRAK Financial Dashboard. Despite headwinds, for the fourth quarter and FY22, it was clear that while some hyaluronic acid (HA) players were able to navigate through seemingly smooth river flows, others hit turbulent whitewater. Aggregate revenue fell in the red for the second quarter in a row primarily due to negative YoY growth in the two leading HA segments, single- and three-injection treatment options.

Among the many topics covered in detail in SmartTRAK's comprehensive Q422/FY22 US Joint Fluid Replacement Market Recap* are:

  • Complete Q422/FY22 Market Overview and Highlights
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Smooth Waters for Some, Turbulent Rapids for Others in Single-Injection Market
  • Which Players are Taking The Wrong Waterway in Multi-Injection Market?
  • Who are the Winners of the Multi-injection Kayak Race?
  • What Companies Were Left in the Wake in the Multi-injection Segment?
  • The Outlook for Joint Fluid Replacement in 2023

On the outlook for 2023 in the US Joint Fluid Replacement market, SmartTRAK expects to see a persistent competitive environment and continued pricing pressure, but the anticipation of ASP stabilization should make for a calmer playing field and enable some to regain market share in certain segments. That said, some unforeseen disruptors may lead to potential internal disruptions like the recent announcement from ...

Read the entire Q422/FY22 US Joint Fluid Replacement Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares. *

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK
Continue Reading
2 min read

Three Ortho Robotics Companies to Watch in 2023

By Shelly Caruso on 5/9/23 9:30 AM

SmartTRAK identifies three orthopedic robotics companies strategically positioned to shake things up this year in the fast-growing robotic-assisted TJA market.

SmartTRAK projects robotic-assisted total knee arthroplasties (TKAs) will account for 48.5% of all US TKAs and 79.6% of all US robotic-assisted joint replacements by 2026E. This growth of robotic-assisted ortho procedures and ongoing adoption of enabling tech continues to drive the US ortho robotics market. In this Market Outlook Article, SmartTRAK identifies and analyzes three robotics companies that may shake things up in 2023 and beyond. They are:

  • Stryker: Racing Towards New Indications in 2023
    • On the heels of a record-breaking quarter in Q422 in terms of MAKO installations in the US and internationally, market-leader Stryker (SYK) announced in its Q422 earnings call highly-anticipated timelines for the Company’s plans to launch ...
  • THINK Surgical: Pursuing Two New Robots in 2023
    • THINK Surgical has a different approach compared to most robotics competitors. The Company focuses on providing robotic systems for joint replacement surgery, with an open implant library as an alternative to closed systems limited to a single manufacturer's implants. At the Canaccord Genuity Healthcare Conference in 2022, the Company revealed plans to ...
  • Globus Medical: Bringing Knee Enabling Tech to Market in 2023
    • Since Globus Medical (GMED) acquired Stelkast in 2019 as a foundation for expanding into the total joint market, an orthopedic robotic system from the Company has been looming on the horizon. In the last two years, GMED has been consistently submitting intellectual property applications related to ...

To read the complete "Three Ortho Robotics Companies to Watch in 2023" Market Outlook article by By Shelly Caruso, SmartTRAK's Market Analyst/Medical Writer, Just click the button below. Download the Ortho Robotics 2023 Article

Continue Reading
2 min read

Spine Themes for 2023: Great Expectations

By Courtney Sheedy on 5/5/23 9:30 AM

For FY23, SmartTRAK expects to see M&A activity create both opportunities and challenges, the impact of positive swings in reimbursement furthering growth in SI joint fusion and disc replacement and for ongoing hospital limitations and the persistent adoption of MIS techniques to perpetuate the movement of spine cases to the ASC environment.

SmartTRAK expects to see several trends evolve in the spine market in 2023, shaped by current events and changing market dynamics in recent years. Over the past several years, organizational consolidation has continued as the market demanded scale to compete. An evolution in innovation and advancements in surgical techniques continues to push categorical growth in minimally invasive surgery (MIS) and other procedures that lean on technology to maximize surgical efficiencies for both patients and surgeons.

In this comprehensive Market Outlook article, SmartTRAK examines, in detail, the following issues confronting the Spine market in the year ahead:

  • Corporate Consolidation Activity is Creating both Opportunities and Headwinds
    • Two important mergers transpired last year which will undoubtedly cause major market disruption in 2023: Orthofix/SeaSpine and Globus/NuVasive. For both deals, SmartTRAK expects to see ...

  • An Evolving Reimbursement Landscape is Driving Continued Growth in SI Joint fusion and Disc Replacement
    • There continue to be two spine procedures commanding attention for similar reasons. Historically, sacroiliac joint (SIJ) fusion and total disc replacement (TDR) have been simple and innovative solutions with limited clinical data available, both plagued with reimbursement challenges. The demand for both has been growing for years ...

  • Ongoing Hospital Constraints and Continued Adoption of MIS Techniques Further Procedural Migration to ASCs
    • The macroeconomic climate has caused systemic budget cutting and restructuring in healthcare, which has challenged staffing abilities in already overburdened facilities. Hospital executives’ demand for efficiency and optimization often put surgeons in a position of ...

To read the complete "Spine Themes for 2023: Great Expectations" Market Outlook article by Courtney Sheedy, SmartTRAK's General Manager, Spine, Just click the button below.Download the Spine Themes 2023 Article

Topics: Spine
Continue Reading
2 min read

A Banner Year: Q422 Ortho Enabling Tech Market Recap

By Elise Wolf on 5/4/23 9:45 AM

Q422 was a banner quarter for ortho enabling tech installations, technological advances and expanding applications on the horizon.

The Q422 WW Ortho Enabling Tech Market was down -7.2% YoY, according to SmartTRAK Financial Dashboard . Stryker (SYK) remained the market leader with 65.1% share, followed by Smith+Nephew (SNN), Zimmer Biomet (ZBH) and DePuy Synthes (JNJ). For detailed Q422 revenues and shares by company in the US, EU and ROW, see the SmartTRAK Ortho Enabling Tech Financial Dashboard .*
 
Among the many topics explored in detail in this comprehensive article are:
  • Strong Robotic Performance Despite Lackluster Revenue from Changing Deal Mix
  • Expanding Robotic Applications Contribute to Growth
  • Other Orthopedic Robotics Moving Forward
  • Orthopedic Enabling Tech Making Inroads into Spine and Vice Versa
  • Navigation Highlights
  • Advances in Augmented Reality
  • Preoperative Planning Highlights

Orthopedic robotics market leader SYK reported that Q422 was a record quarter for MAKO installations, both in the US and internationally, with an unsurpassed number of MAKO installations in ASCs. In Q422, SYK saw ...

Read the entire Q422 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Learn More about Subscribing to SmartTRAK

Continue Reading
2 min read

Sports Medicine and Arthroscopy Highlights at AAOS 2023

By Andy Knapik on 5/2/23 9:30 AM

The American Academy of Orthopaedic Surgeons (AAOS) 2023 Annual Meeting in Las Vegas finally felt like the Academy meetings before COVID knocked the wind out of the industry over the last couple of years, and SmartTRAK was there. The meeting was well attended, the exhibitor floor was bustling with traffic steadily throughout the entire meeting and the talks were all well attended. After the last few years of uncertainty and low attendance, it was good to see a robust and engaging Academy meeting once again. While some of the larger companies may have scaled down their booth space at AAOS, there were plenty of new, smaller and mid-tier companies that stepped up their presence to take advantage of the rejuvenated crowd. So what was the buzz at the meeting?
 
In this article, SmartTRAK highlights the key takeaways from AAOS for companies competing in the Sports Medicine Market, including:
  • The Growing Interest in Biologic-Driven Soft Tissue Fixation
    • It was clear at AAOS that there is a growing interest among sports medicine companies and physicians in the use of biologic-driven soft tissue fixation. Since Smith+Nephew set the stage for ...

  • Small and Mid-Size Players That Aim to Take Share
    • A number of smaller US and OUS-based soft tissue fixation companies were on display at AAOS showing that the market for soft tissue fixation is a popular one where new competitors see growth potential. Companies such as ...

  • The New Companies Helping to Drive Innovation in Arthroscopic Video Technology
    • Arthroscopic video technology was front and center at AAOS 2023 from wireless cameras, disposable cameras and scopes to needle scope technology. While the big boys were showcasing their video technology as always, other companies, including ...

To read the complete "Sports Medicine and Arthroscopy Highlights at AAOS 2023" article by Andy Knapik, SmartTRAK's Senior Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies, click the button below. Download the AAOS 2023 Article

Continue Reading
2 min read

Healthy Gains: Q422/FY22 AWC Market Recap

By Susan Paquette on 5/1/23 9:30 AM

Advanced Dressings and Biologics added healthy gains to the WW Advanced Wound Care market, while External Devices showed minimal growth.

The global Advanced Wound Care market is split geographically, with the US accounting for just over half, followed by Europe and then ROW, due to the US using higher technology products and their allowed reimbursement. SmartTRAK noted a sizeable shift in market share from Q122 to Q422.
 

Among the many topics covered in detail in SmartTRAK's comprehensive Q422/FY22 AWC Market Recap* are:

  • Complete Q422/FY22 AWC Market Overview and Highlights
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • WW Advanced Dressings: Continued Solid Growth
  • Biologics: Growth Remains Healthy but Dips Slightly in Q422
    • Skin Substitutes/CTPs
    • Topical Delivery/Drug
    • Collagen/Active Dressings
    • Traditional NPWT Performance
    • Single-use NPWT Performance 
    • Topical Oxygen and Debridement
  • Growth Analysis – Currency Having a Strong Impact Throughout 2022

The US went from 51.9% share market to 55.3% of the global AWC market, Europe from 29.5% to 26.4% and ROW from 18.6% to 18.3%. The primary reason is ...

Read the entire Q422/FY22 AWC Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.Learn More about Subscribing to SmartTRAK


Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles